MRSA Decolonization Therapy
The standard first-line MRSA decolonization regimen consists of intranasal mupirocin 2% ointment twice daily for 5-10 days combined with topical chlorhexidine gluconate body wash for 5-14 days, reserved for patients with recurrent skin and soft tissue infections despite hygiene measures or ongoing household transmission. 1
When to Consider Decolonization
Decolonization is not routinely recommended for all MRSA carriers. Use it only in these specific scenarios:
- Recurrent SSTI (≥2 episodes at different sites over 6 months) despite optimized wound care and hygiene measures 2
- Ongoing household transmission among close contacts despite hygiene interventions 1
Do not decolonize asymptomatic carriers without recurrent infections or transmission issues—the evidence does not support this practice 2.
Standard Decolonization Protocol
Nasal Component
- Mupirocin 2% ointment applied intranasally twice daily for 5-10 days 1
- Apply to both nostrils using a cotton swab
Body Component (choose one)
- Chlorhexidine gluconate body wash daily for 5-14 days 2, 1
- Dilute bleach baths as alternative: 1 teaspoon per gallon of water (or ¼ cup per ¼ tub/13 gallons), 15 minutes twice weekly for 3 months 2
Oral Chlorhexidine
- Chlorhexidine mouth rinse for throat colonization 3
Critical point: Always reinforce hygiene measures concurrently—decolonization alone without behavioral modification has limited durability 2, 1.
Enhanced Regimens for Difficult Cases
When standard decolonization fails or for multi-site colonization:
Intestinal Colonization
- Oral vancomycin (dosing per institutional protocol) 3
Urinary Tract Colonization
- Trimethoprim-sulfamethoxazole (cotrimoxazole) 3
Vaginal Colonization
- Povidone-iodine vaginal preparations, or
- Chlorhexidine ovula or octenidine solution as alternatives 3
Persistent Carriage After Multiple Failures
- Rifampin plus fusidic acid or rifampin plus doxycycline for 7 days 3, 4
- This combination achieved 87% decolonization success in hospitalized patients with multi-site colonization 3
- Important caveat: Rifampin-based regimens require systemic antibiotics and should be reserved for truly refractory cases given antimicrobial stewardship concerns
Mupirocin Resistance
Critical pitfall: Mupirocin resistance is emerging in some community settings and predicts treatment failure 2, 4. When mupirocin resistance is documented (relative risk of failure 9.4-fold higher 4):
Alternative Nasal Agents
- Povidone-iodine nasal preparations 5
- Chlorhexidine 0.1% with neomycin 0.5% nasal cream (under investigation) 6
- Polyhexanide 0.1% nasal gel (under investigation) 6
However, robust evidence for these alternatives remains limited 7, 6. The TIDE trial attempted to validate alternatives but closed early due to recruitment challenges 6.
Screening and Monitoring
Pre-Decolonization
- Do not routinely culture before decolonization if prior MRSA infection is documented 2
- If screening is performed, swab at least 6 sites: nares, throat, axilla, groin, perineum/rectum, and any wounds 3
Post-Decolonization
- Do not perform surveillance cultures after decolonization in the absence of active infection 2
- Routine post-treatment screening is not recommended and does not improve outcomes 2
Treatment Efficacy and Duration
- 74% of patients achieve clearance at 3 months with standard mupirocin/chlorhexidine/rifampin/doxycycline regimen 4
- 54% maintain clearance at 8 months 4
- Decolonization reduces MRSA colonization across all body sites (nares OR 0.34, throat OR 0.55, axilla/groin OR 0.57) 8
- Higher adherence correlates with better outcomes—emphasize this to patients 8
Household Contact Management
For ongoing transmission:
- Evaluate symptomatic contacts and treat active infections first 1
- Consider decolonization of asymptomatic household contacts using the same regimen 1
- Implement environmental hygiene: focus on high-touch surfaces (doorknobs, counters, bathroom fixtures) with commercial cleaners 1
Common Pitfalls to Avoid
Over-reliance on mupirocin alone: Combination therapy with body decolonization is more effective than nasal mupirocin alone 2, 4
Decolonizing without addressing hygiene: Behavioral interventions (covering wounds, not sharing personal items, hand hygiene) are foundational 2, 1
Treating asymptomatic carriers without recurrence: No evidence supports routine decolonization of one-time carriers 2
Ignoring extra-nasal sites: Throat, perineum, and groin colonization are common (>50% of carriers) and require body decolonization, not just nasal treatment 3
Expecting permanent eradication: Recolonization occurs—set realistic expectations with patients 4, 8